Chen_2023_Mar.Drugs_21_

Reference

Title : Secondary Metabolites from the Coral-Derived Fungus Aspergillus austwickii SCSIO41227 with Pancreatic Lipase and Neuraminidase Inhibitory Activities - Chen_2023_Mar.Drugs_21_
Author(s) : Chen Y , He Y , Pang X , Zhou X , Liu Y , Yang B
Ref : Mar Drugs , 21 : , 2023
Abstract :

The coral-derived fungus Aspergillus austwickii SCSIO41227 from Beibu Gulf yielded four previously uncharacterized compounds, namely asperpentenones B-E (1-4), along with twelve known compounds (5-16). Their structures were elucidated using HRESIMS and NMR ((1)H and (13)C NMR, HSQC, HMBC), among which the stereo-structure of compounds 1-3 was determined by calculated ECD. Furthermore, compounds 1-16 were evaluated in terms of their enzyme (acetylcholinesterase (AChE), pancreatic lipase (PL), and neuraminidase (NA)) inhibitory activities. These bioassay results revealed that compounds 2 and 14 exerted noticeable NA inhibitory effects, with IC(50) values of 31.28 and 73.64 microM, respectively. In addition, compound 3 exhibited a weak inhibitory effect against PL. Furthermore, these compounds showed the potential of inhibiting enzymes in silico docking analysis to demonstrate the interactions between compounds and proteins.

PubMedSearch : Chen_2023_Mar.Drugs_21_
PubMedID: 37999391

Related information

Citations formats

Chen Y, He Y, Pang X, Zhou X, Liu Y, Yang B (2023)
Secondary Metabolites from the Coral-Derived Fungus Aspergillus austwickii SCSIO41227 with Pancreatic Lipase and Neuraminidase Inhibitory Activities
Mar Drugs 21 :

Chen Y, He Y, Pang X, Zhou X, Liu Y, Yang B (2023)
Mar Drugs 21 :